George GOURZOULIDIS

George Gourzoulidis is Managing Partner and Co-Founder of Health Through Evidence, with more than 12 years of Health Technology Assessment and Outcomes Research experience.
He has extensive experience in decision-analytic modeling, data analysis and systematic literature reviews. He has developed HTA submission documents and market access strategies for a wide range of disease areas, including Oncology/Hematology, nephrology, diabetes, autoimmune disorders, rare diseases, infectious diseases, and cardiovascular diseases. George has considerable experience in patient-reported outcomes research, having designed and executed studies in Duchenne muscular dystrophy, ulcerative colitis, rheumatoid arthritis, and Crohn’s disease.

George is also a visiting lecturer in Health Technology Assessment at the postgraduate program «Development of new drugs: research, launch and access”, organized by Medical School of University of Athens. His research focuses on economic evaluation of pharmaceuticals, HTA, pharmaceutical policy, and outcomes research, with publications in high-impact international scientific journals with high impact factors and participating in numerous international and national conferences presenting a variety of scientific research studies.

George also contributes to the scientific community as an ad hoc peer reviewer and guest editor for several international scientific journals.